Abeona Therapeutics Inc.

05/04/2022 | Press release | Distributed by Public on 05/04/2022 05:32

Abeona Therapeutics Announces AAV204, a Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration in Non-Human Primates